telomerase-targeted vaccine (Dendreon)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametelomerase-targeted vaccine (Dendreon)
Drug Alias Namecancer vaccine (Dendreon)cancer immunotherapy (Dendreon)
ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccine
Mechanisms of ActionTelomerase modulators
TargetsTelomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A